Hatano Kazuo, Narita Yuichiro, Araki Hiroshi, Sakai Mitsuhiro
Division of Radiation Oncology, Chiba Cancer Center, 666-2 Nitona-cho, Chuo-ku, Chiba 260-8717, Japan.
Gan To Kagaku Ryoho. 2003 Dec;30(13):2050-5.
Three-dimensional conformal radiation therapy (3D-CRT) conforms a high dose region closer to the target volume than does 2D radiation therapy. IMRT is the advanced form of 3D-CRT. With IMRT technique, using multiple intensity modulated beams, one can deliver a high dose of radiation to the target and a low dose to the surrounding normal structures. IMRT planning provides improved tumor target coverage when compared to 3D-CRT treatment planning. There is significant sparing of critical structures and other normal tissues. IMRT also produces dose distributions capable of delivering different dose prescriptions to multiple targets, providing a new opportunity for differential dose painting to increase the dose selectively to specific image-defined regions. Preliminary findings indicate that IMRT is a new clinically feasible tool in radiation oncology. The initial results of clinical studies demonstrate reduced xerostomia in head and neck cancer and also effectively reduced acute and late occurring toxicities, improving the QOL of patients treated for prostate cancer. According to these studies, IMRT will allow dose escalation, leading to better tumor control without normal tissue damage. On the other hand, there are some problems for IMRT in Japan: There are few medical physicists, which results in radiation technologists playing most clinical technological roles, including some dosimetrical and physical activities. Social recognition and economical and legal support for medical physicists should be established in providing better patient care services.
三维适形放射治疗(3D-CRT)能使高剂量区比二维放射治疗更贴近靶区。调强放射治疗(IMRT)是3D-CRT的进阶形式。运用IMRT技术,通过多个强度调制射束,能够向靶区给予高剂量辐射,而向周围正常组织给予低剂量辐射。与3D-CRT治疗计划相比,IMRT计划能改善肿瘤靶区的覆盖情况。关键结构和其他正常组织能得到显著保护。IMRT还能产生剂量分布,从而能够向多个靶区给予不同的剂量处方,为差异剂量描绘提供了新机会,以便有选择地增加对特定影像界定区域的剂量。初步研究结果表明,IMRT是放射肿瘤学中一种新的临床可行工具。临床研究的初步结果显示,头颈部癌患者的口干症有所减轻,前列腺癌患者的急性和迟发性毒性也得到有效降低,患者的生活质量得到改善。根据这些研究,IMRT将允许增加剂量,从而在不损伤正常组织的情况下更好地控制肿瘤。另一方面,IMRT在日本存在一些问题:医学物理师数量稀少,这导致放射技师承担了大部分临床技术工作,包括一些剂量测定和物理方面的工作。在提供更好的患者护理服务方面,应确立对医学物理师的社会认可以及经济和法律支持。